Tarsus Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TARSUS, and when can generic versions of TARSUS drugs launch?
TARSUS has one approved drug.
There are six US patents protecting TARSUS drugs.
There are thirty-nine patent family members on TARSUS drugs in twenty-five countries and fifteen supplementary protection certificates in fifteen countries.
Drugs and US Patents for Tarsus
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tarsus | XDEMVY | lotilaner | SOLUTION/DROPS;OPHTHALMIC | 217603-001 | Jul 24, 2023 | RX | Yes | Yes | 11,752,137 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Tarsus | XDEMVY | lotilaner | SOLUTION/DROPS;OPHTHALMIC | 217603-001 | Jul 24, 2023 | RX | Yes | Yes | 11,690,827 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Tarsus | XDEMVY | lotilaner | SOLUTION/DROPS;OPHTHALMIC | 217603-001 | Jul 24, 2023 | RX | Yes | Yes | 11,197,847 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Tarsus | XDEMVY | lotilaner | SOLUTION/DROPS;OPHTHALMIC | 217603-001 | Jul 24, 2023 | RX | Yes | Yes | 8,383,659 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Tarsus | XDEMVY | lotilaner | SOLUTION/DROPS;OPHTHALMIC | 217603-001 | Jul 24, 2023 | RX | Yes | Yes | 10,835,517 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Tarsus | XDEMVY | lotilaner | SOLUTION/DROPS;OPHTHALMIC | 217603-001 | Jul 24, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Tarsus Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2021506971 | ⤷ Try a Trial |
Netherlands | 300891 | ⤷ Try a Trial |
New Zealand | 766141 | ⤷ Try a Trial |
Hungary | S1700034 | ⤷ Try a Trial |
Taiwan | 201024289 | ⤷ Try a Trial |
South Africa | 202004155 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Tarsus Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2379537 | 132017000099235 | Italy | ⤷ Try a Trial | PRODUCT NAME: LOTILANER(CREDELIO); AUTHORISATION NUMBER(S) AND DATE(S): EU/2/17/206, 20170427 |
2379537 | 699 | Finland | ⤷ Try a Trial | |
2379537 | 17C0006 | France | ⤷ Try a Trial | PRODUCT NAME: LOTILANER; REGISTRATION NO/DATE: EU/2/17/206 20170427 |
2379537 | CR 2017 00034 | Denmark | ⤷ Try a Trial | PRODUCT NAME: LOTILANER OG SALTE DERAF; REG. NO/DATE: EU/2/17/206/001-015 20170427 |
2379537 | C201730034 | Spain | ⤷ Try a Trial | PRODUCT NAME: LOTILANER Y SALES DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/2/17/206; DATE OF AUTHORISATION: 20170425; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/2/17/206; DATE OF FIRST AUTHORISATION IN EEA: 20170425 |
2379537 | 1790037-4 | Sweden | ⤷ Try a Trial | PRODUCT NAME: LOTILANER AND SALTS THEREOF; REG. NO/DATE: EU/2/17/206 20170427 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.